LifeMD, Inc. 10-Q

ITEM 5. OTHER INFORMATION None. 38 ITEM 6. EXHIBITS Incorporated by Reference Exhibit Number Exhibit Description Form Exhibit Filing Date/Period End Date 10.1 # Third Amended and Restated 2020 Equity and Incentive Plan 8-K 10.1 06/18/2024 31.1* Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer. 31.2* Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer. 32.1** Section 1350 Certification of Chief Executive Officer. 32.2** Section 1350 Certification of Chief Financial Officer. 101.INS* Inline XBRL Instance Document 101.SCH* Inline XBRL Taxonomy Extension Schema Document 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document 104* Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS) # Indicates management contract or compensatory plan, contract or arrangement. * Filed herewith. ** Furnished herewith 39 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. LIFEMD, INC. By: /s/ Justin Schreiber Justin Schreiber Chief Executive Officer and Chairman of the Board of Directors Date: August 7, 2024 By: /s/ Marc Benathen Marc Benathen Chief Financial Officer Date: August 7, 2024 By: /s/ Maria Stan Maria Stan Chief Accounting Officer Date: August 7, 2024 40